The association may, therefore, reflect the higher presence of risk factors in semaglutide users rather than an effect of semaglutide
[155] demonstrated that LA administration significantly reduced OVA-specific IgE, IgG1, IL-17, STAT3, and RORt levels and increased IL-10 and Foxp3 levels
Instead, users are encouraged to take the supplement daily for several weeks
In Phase 2 trials, participants on the highest dose (12mg weekly) lost an average of 24.2% of their body weight over 48 weeks, results that surpass both semaglutide and tirzepatide at their respective trial endpoints
CONNECT WITH MICHELLE WHITE Website / free discovery call: theinspiredwellnesscoach.com Instagram & Facebook: @TheInspiredWellnessCoach Inspired Wellness Podcast: MENTIONED IN THIS EPISODE Atomic Habits by James Clear (habit-formation book referenced in the stress/habits discussion): RESEARCH REFERENCED IN THIS EPISODE The "not feeling like myself" perimenopause study (63% of women affected at least half the time): Data on GLP-1 medications and lean muscle mass loss ("skinny fat"): No comments yet
